Request Free Sample ×
Heart Scan Market Research Report - Global Forecast till 2035 Infographic

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Heart Scan Market

ID: MRFR/MED/3784-HCR
110 Pages
Vikita Thakur
Last Updated: April 06, 2026

Heart Scan Market Research Report Information: By Types (Electron Beam Computed Tomography, Angiocardiography) Indication (Congenital Heart Disease, Coronary Arteries Blockage) End-User (Hospitals & Clinics, Diagnostic Centers) - Global Forecast till 2035.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Heart Scan Market Infographic
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
  2.   1.1 EXECUTIVE SUMMARY
  3.     1.1.1 Market Overview
  4.     1.1.2 Key Findings
  5.     1.1.3 Market Segmentation
  6.     1.1.4 Competitive Landscape
  7.     1.1.5 Challenges and Opportunities
  8.     1.1.6 Future Outlook
  9. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
  10.   2.1 MARKET INTRODUCTION
  11.     2.1.1 Definition
  12.     2.1.2 Scope of the study
  13.       2.1.2.1 Research Objective
  14.       2.1.2.2 Assumption
  15.       2.1.2.3 Limitations
  16.   2.2 RESEARCH METHODOLOGY
  17.     2.2.1 Overview
  18.     2.2.2 Data Mining
  19.     2.2.3 Secondary Research
  20.     2.2.4 Primary Research
  21.       2.2.4.1 Primary Interviews and Information Gathering Process
  22.       2.2.4.2 Breakdown of Primary Respondents
  23.     2.2.5 Forecasting Model
  24.     2.2.6 Market Size Estimation
  25.       2.2.6.1 Bottom-Up Approach
  26.       2.2.6.2 Top-Down Approach
  27.     2.2.7 Data Triangulation
  28.     2.2.8 Validation
  29. 3 SECTION III: QUALITATIVE ANALYSIS
  30.   3.1 MARKET DYNAMICS
  31.     3.1.1 Overview
  32.     3.1.2 Drivers
  33.     3.1.3 Restraints
  34.     3.1.4 Opportunities
  35.   3.2 MARKET FACTOR ANALYSIS
  36.     3.2.1 Value chain Analysis
  37.     3.2.2 Porter's Five Forces Analysis
  38.       3.2.2.1 Bargaining Power of Suppliers
  39.       3.2.2.2 Bargaining Power of Buyers
  40.       3.2.2.3 Threat of New Entrants
  41.       3.2.2.4 Threat of Substitutes
  42.       3.2.2.5 Intensity of Rivalry
  43.     3.2.3 COVID-19 Impact Analysis
  44.       3.2.3.1 Market Impact Analysis
  45.       3.2.3.2 Regional Impact
  46.       3.2.3.3 Opportunity and Threat Analysis
  47. 4 SECTION IV: QUANTITATIVE ANALYSIS
  48.   4.1 Healthcare, BY Type (USD Billion)
  49.     4.1.1 electron beam computed tomography
  50.     4.1.2 nuclear heart scan
  51.     4.1.3 echocardiogram
  52.     4.1.4 cardiac catheterization
  53.     4.1.5 coronary arteriography
  54.     4.1.6 angiocardiography
  55.     4.1.7 others
  56.   4.2 Healthcare, BY Indication (USD Billion)
  57.     4.2.1 congenital heart disease
  58.     4.2.2 coronary arteries blockage
  59.     4.2.3 defects or injury to the heart’s four primary valves
  60.     4.2.4 blood clots within the heart’s chambers
  61.     4.2.5 tumors in or on the heart
  62.     4.2.6 others
  63.   4.3 Healthcare, BY End Users (USD Billion)
  64.     4.3.1 hospitals & clinics
  65.     4.3.2 diagnostic centers
  66.     4.3.3 cardiac care centers
  67.     4.3.4 ambulatory centers & home care
  68.     4.3.5 academic institutes
  69.     4.3.6 others
  70.   4.4 Healthcare, BY Region (USD Billion)
  71.     4.4.1 North America
  72.       4.4.1.1 US
  73.       4.4.1.2 Canada
  74.     4.4.2 Europe
  75.       4.4.2.1 Germany
  76.       4.4.2.2 UK
  77.       4.4.2.3 France
  78.       4.4.2.4 Russia
  79.       4.4.2.5 Italy
  80.       4.4.2.6 Spain
  81.       4.4.2.7 Rest of Europe
  82.     4.4.3 APAC
  83.       4.4.3.1 China
  84.       4.4.3.2 India
  85.       4.4.3.3 Japan
  86.       4.4.3.4 South Korea
  87.       4.4.3.5 Malaysia
  88.       4.4.3.6 Thailand
  89.       4.4.3.7 Indonesia
  90.       4.4.3.8 Rest of APAC
  91.     4.4.4 South America
  92.       4.4.4.1 Brazil
  93.       4.4.4.2 Mexico
  94.       4.4.4.3 Argentina
  95.       4.4.4.4 Rest of South America
  96.     4.4.5 MEA
  97.       4.4.5.1 GCC Countries
  98.       4.4.5.2 South Africa
  99.       4.4.5.3 Rest of MEA
  100. 5 SECTION V: COMPETITIVE ANALYSIS
  101.   5.1 Competitive Landscape
  102.     5.1.1 Overview
  103.     5.1.2 Competitive Analysis
  104.     5.1.3 Market share Analysis
  105.     5.1.4 Major Growth Strategy in the Healthcare
  106.     5.1.5 Competitive Benchmarking
  107.     5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  108.     5.1.7 Key developments and growth strategies
  109.       5.1.7.1 New Product Launch/Service Deployment
  110.       5.1.7.2 Merger & Acquisitions
  111.       5.1.7.3 Joint Ventures
  112.     5.1.8 Major Players Financial Matrix
  113.       5.1.8.1 Sales and Operating Income
  114.       5.1.8.2 Major Players R&D Expenditure. 2023
  115.   5.2 Company Profiles
  116.     5.2.1 Siemens Healthineers (DE)
  117.       5.2.1.1 Financial Overview
  118.       5.2.1.2 Products Offered
  119.       5.2.1.3 Key Developments
  120.       5.2.1.4 SWOT Analysis
  121.       5.2.1.5 Key Strategies
  122.     5.2.2 GE Healthcare (US)
  123.       5.2.2.1 Financial Overview
  124.       5.2.2.2 Products Offered
  125.       5.2.2.3 Key Developments
  126.       5.2.2.4 SWOT Analysis
  127.       5.2.2.5 Key Strategies
  128.     5.2.3 Philips Healthcare (NL)
  129.       5.2.3.1 Financial Overview
  130.       5.2.3.2 Products Offered
  131.       5.2.3.3 Key Developments
  132.       5.2.3.4 SWOT Analysis
  133.       5.2.3.5 Key Strategies
  134.     5.2.4 Canon Medical Systems (JP)
  135.       5.2.4.1 Financial Overview
  136.       5.2.4.2 Products Offered
  137.       5.2.4.3 Key Developments
  138.       5.2.4.4 SWOT Analysis
  139.       5.2.4.5 Key Strategies
  140.     5.2.5 Samsung Medison (KR)
  141.       5.2.5.1 Financial Overview
  142.       5.2.5.2 Products Offered
  143.       5.2.5.3 Key Developments
  144.       5.2.5.4 SWOT Analysis
  145.       5.2.5.5 Key Strategies
  146.     5.2.6 Fujifilm Holdings (JP)
  147.       5.2.6.1 Financial Overview
  148.       5.2.6.2 Products Offered
  149.       5.2.6.3 Key Developments
  150.       5.2.6.4 SWOT Analysis
  151.       5.2.6.5 Key Strategies
  152.     5.2.7 Mindray (CN)
  153.       5.2.7.1 Financial Overview
  154.       5.2.7.2 Products Offered
  155.       5.2.7.3 Key Developments
  156.       5.2.7.4 SWOT Analysis
  157.       5.2.7.5 Key Strategies
  158.     5.2.8 Hitachi Medical Systems (JP)
  159.       5.2.8.1 Financial Overview
  160.       5.2.8.2 Products Offered
  161.       5.2.8.3 Key Developments
  162.       5.2.8.4 SWOT Analysis
  163.       5.2.8.5 Key Strategies
  164.     5.2.9 Agfa HealthCare (BE)
  165.       5.2.9.1 Financial Overview
  166.       5.2.9.2 Products Offered
  167.       5.2.9.3 Key Developments
  168.       5.2.9.4 SWOT Analysis
  169.       5.2.9.5 Key Strategies
  170.   5.3 Appendix
  171.     5.3.1 References
  172.     5.3.2 Related Reports
  173. 6 LIST OF FIGURES
  174.   6.1 MARKET SYNOPSIS
  175.   6.2 NORTH AMERICA MARKET ANALYSIS
  176.   6.3 US MARKET ANALYSIS BY TYPE
  177.   6.4 US MARKET ANALYSIS BY INDICATION
  178.   6.5 US MARKET ANALYSIS BY END USERS
  179.   6.6 CANADA MARKET ANALYSIS BY TYPE
  180.   6.7 CANADA MARKET ANALYSIS BY INDICATION
  181.   6.8 CANADA MARKET ANALYSIS BY END USERS
  182.   6.9 EUROPE MARKET ANALYSIS
  183.   6.10 GERMANY MARKET ANALYSIS BY TYPE
  184.   6.11 GERMANY MARKET ANALYSIS BY INDICATION
  185.   6.12 GERMANY MARKET ANALYSIS BY END USERS
  186.   6.13 UK MARKET ANALYSIS BY TYPE
  187.   6.14 UK MARKET ANALYSIS BY INDICATION
  188.   6.15 UK MARKET ANALYSIS BY END USERS
  189.   6.16 FRANCE MARKET ANALYSIS BY TYPE
  190.   6.17 FRANCE MARKET ANALYSIS BY INDICATION
  191.   6.18 FRANCE MARKET ANALYSIS BY END USERS
  192.   6.19 RUSSIA MARKET ANALYSIS BY TYPE
  193.   6.20 RUSSIA MARKET ANALYSIS BY INDICATION
  194.   6.21 RUSSIA MARKET ANALYSIS BY END USERS
  195.   6.22 ITALY MARKET ANALYSIS BY TYPE
  196.   6.23 ITALY MARKET ANALYSIS BY INDICATION
  197.   6.24 ITALY MARKET ANALYSIS BY END USERS
  198.   6.25 SPAIN MARKET ANALYSIS BY TYPE
  199.   6.26 SPAIN MARKET ANALYSIS BY INDICATION
  200.   6.27 SPAIN MARKET ANALYSIS BY END USERS
  201.   6.28 REST OF EUROPE MARKET ANALYSIS BY TYPE
  202.   6.29 REST OF EUROPE MARKET ANALYSIS BY INDICATION
  203.   6.30 REST OF EUROPE MARKET ANALYSIS BY END USERS
  204.   6.31 APAC MARKET ANALYSIS
  205.   6.32 CHINA MARKET ANALYSIS BY TYPE
  206.   6.33 CHINA MARKET ANALYSIS BY INDICATION
  207.   6.34 CHINA MARKET ANALYSIS BY END USERS
  208.   6.35 INDIA MARKET ANALYSIS BY TYPE
  209.   6.36 INDIA MARKET ANALYSIS BY INDICATION
  210.   6.37 INDIA MARKET ANALYSIS BY END USERS
  211.   6.38 JAPAN MARKET ANALYSIS BY TYPE
  212.   6.39 JAPAN MARKET ANALYSIS BY INDICATION
  213.   6.40 JAPAN MARKET ANALYSIS BY END USERS
  214.   6.41 SOUTH KOREA MARKET ANALYSIS BY TYPE
  215.   6.42 SOUTH KOREA MARKET ANALYSIS BY INDICATION
  216.   6.43 SOUTH KOREA MARKET ANALYSIS BY END USERS
  217.   6.44 MALAYSIA MARKET ANALYSIS BY TYPE
  218.   6.45 MALAYSIA MARKET ANALYSIS BY INDICATION
  219.   6.46 MALAYSIA MARKET ANALYSIS BY END USERS
  220.   6.47 THAILAND MARKET ANALYSIS BY TYPE
  221.   6.48 THAILAND MARKET ANALYSIS BY INDICATION
  222.   6.49 THAILAND MARKET ANALYSIS BY END USERS
  223.   6.50 INDONESIA MARKET ANALYSIS BY TYPE
  224.   6.51 INDONESIA MARKET ANALYSIS BY INDICATION
  225.   6.52 INDONESIA MARKET ANALYSIS BY END USERS
  226.   6.53 REST OF APAC MARKET ANALYSIS BY TYPE
  227.   6.54 REST OF APAC MARKET ANALYSIS BY INDICATION
  228.   6.55 REST OF APAC MARKET ANALYSIS BY END USERS
  229.   6.56 SOUTH AMERICA MARKET ANALYSIS
  230.   6.57 BRAZIL MARKET ANALYSIS BY TYPE
  231.   6.58 BRAZIL MARKET ANALYSIS BY INDICATION
  232.   6.59 BRAZIL MARKET ANALYSIS BY END USERS
  233.   6.60 MEXICO MARKET ANALYSIS BY TYPE
  234.   6.61 MEXICO MARKET ANALYSIS BY INDICATION
  235.   6.62 MEXICO MARKET ANALYSIS BY END USERS
  236.   6.63 ARGENTINA MARKET ANALYSIS BY TYPE
  237.   6.64 ARGENTINA MARKET ANALYSIS BY INDICATION
  238.   6.65 ARGENTINA MARKET ANALYSIS BY END USERS
  239.   6.66 REST OF SOUTH AMERICA MARKET ANALYSIS BY TYPE
  240.   6.67 REST OF SOUTH AMERICA MARKET ANALYSIS BY INDICATION
  241.   6.68 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USERS
  242.   6.69 MEA MARKET ANALYSIS
  243.   6.70 GCC COUNTRIES MARKET ANALYSIS BY TYPE
  244.   6.71 GCC COUNTRIES MARKET ANALYSIS BY INDICATION
  245.   6.72 GCC COUNTRIES MARKET ANALYSIS BY END USERS
  246.   6.73 SOUTH AFRICA MARKET ANALYSIS BY TYPE
  247.   6.74 SOUTH AFRICA MARKET ANALYSIS BY INDICATION
  248.   6.75 SOUTH AFRICA MARKET ANALYSIS BY END USERS
  249.   6.76 REST OF MEA MARKET ANALYSIS BY TYPE
  250.   6.77 REST OF MEA MARKET ANALYSIS BY INDICATION
  251.   6.78 REST OF MEA MARKET ANALYSIS BY END USERS
  252.   6.79 KEY BUYING CRITERIA OF HEALTHCARE
  253.   6.80 RESEARCH PROCESS OF MRFR
  254.   6.81 DRO ANALYSIS OF HEALTHCARE
  255.   6.82 DRIVERS IMPACT ANALYSIS: HEALTHCARE
  256.   6.83 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
  257.   6.84 SUPPLY / VALUE CHAIN: HEALTHCARE
  258.   6.85 HEALTHCARE, BY TYPE, 2024 (% SHARE)
  259.   6.86 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Billion)
  260.   6.87 HEALTHCARE, BY INDICATION, 2024 (% SHARE)
  261.   6.88 HEALTHCARE, BY INDICATION, 2024 TO 2035 (USD Billion)
  262.   6.89 HEALTHCARE, BY END USERS, 2024 (% SHARE)
  263.   6.90 HEALTHCARE, BY END USERS, 2024 TO 2035 (USD Billion)
  264.   6.91 BENCHMARKING OF MAJOR COMPETITORS
  265. 7 LIST OF TABLES
  266.   7.1 LIST OF ASSUMPTIONS
  267.     7.1.1
  268.   7.2 North America MARKET SIZE ESTIMATES; FORECAST
  269.     7.2.1 BY TYPE, 2025-2035 (USD Billion)
  270.     7.2.2 BY INDICATION, 2025-2035 (USD Billion)
  271.     7.2.3 BY END USERS, 2025-2035 (USD Billion)
  272.   7.3 US MARKET SIZE ESTIMATES; FORECAST
  273.     7.3.1 BY TYPE, 2025-2035 (USD Billion)
  274.     7.3.2 BY INDICATION, 2025-2035 (USD Billion)
  275.     7.3.3 BY END USERS, 2025-2035 (USD Billion)
  276.   7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  277.     7.4.1 BY TYPE, 2025-2035 (USD Billion)
  278.     7.4.2 BY INDICATION, 2025-2035 (USD Billion)
  279.     7.4.3 BY END USERS, 2025-2035 (USD Billion)
  280.   7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  281.     7.5.1 BY TYPE, 2025-2035 (USD Billion)
  282.     7.5.2 BY INDICATION, 2025-2035 (USD Billion)
  283.     7.5.3 BY END USERS, 2025-2035 (USD Billion)
  284.   7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  285.     7.6.1 BY TYPE, 2025-2035 (USD Billion)
  286.     7.6.2 BY INDICATION, 2025-2035 (USD Billion)
  287.     7.6.3 BY END USERS, 2025-2035 (USD Billion)
  288.   7.7 UK MARKET SIZE ESTIMATES; FORECAST
  289.     7.7.1 BY TYPE, 2025-2035 (USD Billion)
  290.     7.7.2 BY INDICATION, 2025-2035 (USD Billion)
  291.     7.7.3 BY END USERS, 2025-2035 (USD Billion)
  292.   7.8 France MARKET SIZE ESTIMATES; FORECAST
  293.     7.8.1 BY TYPE, 2025-2035 (USD Billion)
  294.     7.8.2 BY INDICATION, 2025-2035 (USD Billion)
  295.     7.8.3 BY END USERS, 2025-2035 (USD Billion)
  296.   7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  297.     7.9.1 BY TYPE, 2025-2035 (USD Billion)
  298.     7.9.2 BY INDICATION, 2025-2035 (USD Billion)
  299.     7.9.3 BY END USERS, 2025-2035 (USD Billion)
  300.   7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  301.     7.10.1 BY TYPE, 2025-2035 (USD Billion)
  302.     7.10.2 BY INDICATION, 2025-2035 (USD Billion)
  303.     7.10.3 BY END USERS, 2025-2035 (USD Billion)
  304.   7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  305.     7.11.1 BY TYPE, 2025-2035 (USD Billion)
  306.     7.11.2 BY INDICATION, 2025-2035 (USD Billion)
  307.     7.11.3 BY END USERS, 2025-2035 (USD Billion)
  308.   7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  309.     7.12.1 BY TYPE, 2025-2035 (USD Billion)
  310.     7.12.2 BY INDICATION, 2025-2035 (USD Billion)
  311.     7.12.3 BY END USERS, 2025-2035 (USD Billion)
  312.   7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  313.     7.13.1 BY TYPE, 2025-2035 (USD Billion)
  314.     7.13.2 BY INDICATION, 2025-2035 (USD Billion)
  315.     7.13.3 BY END USERS, 2025-2035 (USD Billion)
  316.   7.14 China MARKET SIZE ESTIMATES; FORECAST
  317.     7.14.1 BY TYPE, 2025-2035 (USD Billion)
  318.     7.14.2 BY INDICATION, 2025-2035 (USD Billion)
  319.     7.14.3 BY END USERS, 2025-2035 (USD Billion)
  320.   7.15 India MARKET SIZE ESTIMATES; FORECAST
  321.     7.15.1 BY TYPE, 2025-2035 (USD Billion)
  322.     7.15.2 BY INDICATION, 2025-2035 (USD Billion)
  323.     7.15.3 BY END USERS, 2025-2035 (USD Billion)
  324.   7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  325.     7.16.1 BY TYPE, 2025-2035 (USD Billion)
  326.     7.16.2 BY INDICATION, 2025-2035 (USD Billion)
  327.     7.16.3 BY END USERS, 2025-2035 (USD Billion)
  328.   7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  329.     7.17.1 BY TYPE, 2025-2035 (USD Billion)
  330.     7.17.2 BY INDICATION, 2025-2035 (USD Billion)
  331.     7.17.3 BY END USERS, 2025-2035 (USD Billion)
  332.   7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  333.     7.18.1 BY TYPE, 2025-2035 (USD Billion)
  334.     7.18.2 BY INDICATION, 2025-2035 (USD Billion)
  335.     7.18.3 BY END USERS, 2025-2035 (USD Billion)
  336.   7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  337.     7.19.1 BY TYPE, 2025-2035 (USD Billion)
  338.     7.19.2 BY INDICATION, 2025-2035 (USD Billion)
  339.     7.19.3 BY END USERS, 2025-2035 (USD Billion)
  340.   7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  341.     7.20.1 BY TYPE, 2025-2035 (USD Billion)
  342.     7.20.2 BY INDICATION, 2025-2035 (USD Billion)
  343.     7.20.3 BY END USERS, 2025-2035 (USD Billion)
  344.   7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  345.     7.21.1 BY TYPE, 2025-2035 (USD Billion)
  346.     7.21.2 BY INDICATION, 2025-2035 (USD Billion)
  347.     7.21.3 BY END USERS, 2025-2035 (USD Billion)
  348.   7.22 South America MARKET SIZE ESTIMATES; FORECAST
  349.     7.22.1 BY TYPE, 2025-2035 (USD Billion)
  350.     7.22.2 BY INDICATION, 2025-2035 (USD Billion)
  351.     7.22.3 BY END USERS, 2025-2035 (USD Billion)
  352.   7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  353.     7.23.1 BY TYPE, 2025-2035 (USD Billion)
  354.     7.23.2 BY INDICATION, 2025-2035 (USD Billion)
  355.     7.23.3 BY END USERS, 2025-2035 (USD Billion)
  356.   7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  357.     7.24.1 BY TYPE, 2025-2035 (USD Billion)
  358.     7.24.2 BY INDICATION, 2025-2035 (USD Billion)
  359.     7.24.3 BY END USERS, 2025-2035 (USD Billion)
  360.   7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  361.     7.25.1 BY TYPE, 2025-2035 (USD Billion)
  362.     7.25.2 BY INDICATION, 2025-2035 (USD Billion)
  363.     7.25.3 BY END USERS, 2025-2035 (USD Billion)
  364.   7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  365.     7.26.1 BY TYPE, 2025-2035 (USD Billion)
  366.     7.26.2 BY INDICATION, 2025-2035 (USD Billion)
  367.     7.26.3 BY END USERS, 2025-2035 (USD Billion)
  368.   7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  369.     7.27.1 BY TYPE, 2025-2035 (USD Billion)
  370.     7.27.2 BY INDICATION, 2025-2035 (USD Billion)
  371.     7.27.3 BY END USERS, 2025-2035 (USD Billion)
  372.   7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  373.     7.28.1 BY TYPE, 2025-2035 (USD Billion)
  374.     7.28.2 BY INDICATION, 2025-2035 (USD Billion)
  375.     7.28.3 BY END USERS, 2025-2035 (USD Billion)
  376.   7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  377.     7.29.1 BY TYPE, 2025-2035 (USD Billion)
  378.     7.29.2 BY INDICATION, 2025-2035 (USD Billion)
  379.     7.29.3 BY END USERS, 2025-2035 (USD Billion)
  380.   7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  381.     7.30.1 BY TYPE, 2025-2035 (USD Billion)
  382.     7.30.2 BY INDICATION, 2025-2035 (USD Billion)
  383.     7.30.3 BY END USERS, 2025-2035 (USD Billion)
  384.   7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  385.     7.31.1
  386.   7.32 ACQUISITION/PARTNERSHIP
  387.     7.32.1

Healthcare Market Segmentation

Healthcare By Type (USD Billion, 2025-2035)

  • electron beam computed tomography
  • nuclear heart scan
  • echocardiogram
  • cardiac catheterization
  • coronary arteriography
  • angiocardiography
  • others

Healthcare By Indication (USD Billion, 2025-2035)

  • congenital heart disease
  • coronary arteries blockage
  • defects or injury to the heart’s four primary valves
  • blood clots within the heart’s chambers
  • tumors in or on the heart
  • others

Healthcare By End Users (USD Billion, 2025-2035)

  • hospitals & clinics
  • diagnostic centers
  • cardiac care centers
  • ambulatory centers & home care
  • academic institutes
  • others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories
Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓